title: Prolonged fever after Infliximab infusion.
abstract: Pharmacologic management for ulcerative colitis (UC) has recently been expanded to include anti- tumor necrosis factor (TNF) therapy for severe disease. Infliximab, a chimeric monoclonal antibody directed again TNF α was first tested in patients with Crohn's disease. In addition to serious infections, malignancy, drug induced lupus and other autoimmune diseases, serum sickness-like reactions, neurological disease, and infusion reactions further complicate the use of Infliximab. We report a case of prolonged fever after Infliximab infusion to treat steroid refractory UC.
authors.affiliation: Jennifer Katz, Michael Frank, New York University Medical Center, New York, NY 10016, United States.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Katz
authors.forename: Michael
authors.initials: M
authors.lastname: Frank